Medical management of Meniere's disease

Ear, Nose and Throat Journal

Volumn 76, Issue 9, 1997, Pages 634-640

  Brookes, Gerald B ^a  

^a NATIONAL HOSPITAL FOR NEUROLOGY AND NEUROSURGERY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID; ADRENERGIC RECEPTOR BLOCKING AGENT; AMILORIDE; ANTIHISTAMINIC AGENT; BETAHISTINE; CALCIUM ANTAGONIST; CHOLINERGIC RECEPTOR BLOCKING AGENT; CINNARIZINE; DIAZEPAM; DIMENHYDRINATE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIPHENHYDRAMINE; FUROSEMIDE; GENTAMICIN; GLYCEROL; HISTAMINE H1 RECEPTOR; HISTAMINE H3 RECEPTOR; HYDROCHLOROTHIAZIDE; IMMUNOGLOBULIN G; MECLOZINE; METOCLOPRAMIDE; NAFTIDROFURYL OXALATE; ONDANSETRON; OSMOTIC DIURETIC AGENT; PROCHLORPERAZINE MALEATE; PROMETHAZINE; SCOPOLAMINE; STREPTOMYCIN; UNINDEXED DRUG; UREA;

ANTICHOLINERGIC EFFECT; ANTIEMETIC ACTIVITY; CLINICAL TRIAL; DIURESIS; DROWSINESS; DRUG EFFICACY; DRUG INDICATION; HUMAN; MENIERE DISEASE; NONHUMAN; ORAL DRUG ADMINISTRATION; PATHOPHYSIOLOGY; PLASMAPHERESIS; REVIEW; SEDATION; TRANSDERMAL DRUG ADMINISTRATION; VERTIGO; VISUAL IMPAIRMENT; XEROSTOMIA; PROGNOSIS;

HUMANS; MENIERE'S DISEASE; PROGNOSIS;

EID: 0030610126     PISSN: 01455613     EISSN: None     Source Type: Journal    
DOI: 10.1177/014556139707600908     Document Type: Review

References (48)

1. Thomsen J, Bech P, Prytz S, et al. Meniere's disease: Lithium treatment (demonstration of placebo effect in a double-blind cross-over trial). Clin Otolaryngol 1979; 4:119-23.
2. Philipszoon AJ. Influence of cinnarizine on the labyrinth and on vertigo. Clin Pharmacol Ther 1962; 3(2):184-90.
3. Klockhoff I, Lindblom U. Meniere's disease and hydrochlorothiazide: A critical analysis of symptoms and therapeutic effects. Acta Otolaryngol 1967; 63:347-65.
4. Frew IJC, Menon GW. Betahistine hydrochloride in Meniere's disease. Postgrad Med J 1976; 52:501-3.
5. Wilmot TJ, Menon GW. Betahistine in Meniere's disease. J Laryngol Otol 1976; 90:833-40.
6. Towse G. Cinnanzine: A labyrinthine sedative. J Laryngol Otol 1980; 94:1009-15.
7. Van Deelen GW, Huizing EH. The use of a diuretic (Diazide) in the treatment of Meniere's disease. ORL 1986; 48:287-92.
8. Wennmo C, Bergenius J, Henriksson NG, et al. Transdermal scopolamine and dimenhydrinate in treatment of acute vertigo, in Graham MD, Kemink JL (eds): The Vestibular System: Neurophysiologic and Clinical Research. New York, Raven Press, 1987.
9. Ruckenstein MJ, Rutka JA, Hawke M. The treatment of Meniere's disease: Torok revisited. Laryngoscope 1991; 101:211-18.
10. Torok N. Old and new in Meniere's disease. Laryngoscope 1977; 87:1870-7.
11. Silverstein H, Smouha E, Jones R. Natural history versus surgery for Meniere's disease. Otolaryngol Head Neck Surg 1989; 100 6-16.
12. Wamsley JK, Lewis MS, Young WS, et al. Autoradiographic localization of cholinergic receptors in rat brainstem. J Neurosci 1981; 1:176-91.
13. Palacios JM, Wamsley JK, Kuhar MJ. The distribution of histamine H1 receptors in rat brain: An autoradiographic study. Neuroscience 1981; 6:15-37.
14. Takeda N, Morita M, Hasegawa S, et al. Neuropharmacology of motion sickness and emesis. Acta Otolaryngol (Stockh) 1993; 501(Suppl):10-15.
15. Kirsten EB, Schoener EP, Wang SC. Effects of d-amphetamine on single vestibular neurones. J Pharmacol Exp Ther 1974; 191:377-83.
16. Jongkees LBW, Philipszoon AJ. Some nystagmographical methods for the investigation of the effects of drugs upon the labyrinth. Acta Physiol Pharmacol (Netherlands) 1960; 9:240-75.
17. Cobb S, Coen LW, Gitomer SL, et al. Effect of cinnarizine on nystagmus induced by rotation deceleration. ENT Month 1976; 55:24-30.
18. O'Donoghue BM. Anaesthesia for ENT surgery, in Morgan M, Hall GH (eds): Short Textbook of Anaesthesia. London, Churchill Livingstone, 1996. In press.
19. Shinkawa H, Kimura RS. Effect of diuretics on endolymphatic hydrops. Acta Otolaryngol (Stockh) 1986; 101:43-52.
20. Klockhoff IM, Lindblom U, Stahle J. Diuretic treatment of Meniere's disease. Arch Otolaryngol 1974; 100:262-5.
21. Jackson CG, Glasscock ME, Davis WE, et al. Medical management of Meniere's disease. Ann Otol Rhinol Laryngol 1981; 90:142-7.
22. Moffat DA, Gibson WPR, Ramsden RT, et al. Transtympanic electrocochleography during glycerol dehydration. Acta Otolaryngol 1978; 85:158-66.
23. Brookes GB, Morrison AW, Richard R. Otoadmittance changes following glycerol dehydration in Meniere's disease. Acta Otolaryngol 1984; 98:30-41.
24. Angelborg C, Klockhoff I, Stahle J. Urea and hearing in patients with Meniere's disease. Scand Audiol 1977; 6:143-6.
25. Brookes GB, Hodge RA, Booth JB, et al. The immediate effects of acetazolamide in Meniere's disease. J Laryngol Otol 1982; 96:57-72.
26. Brookes GB, Booth JB. Oral acetazolamide in Meniere's disease. J Laryngol Otol 1984; 98:1087-95.
27. Cook P, James I. Drug therapy Cerebral vasodilators. N Engl J Med 1981; 305:1508-13.
28. Van Nueten JM, Janssen PAJ. Comparative study of the effects of flunarizine and cinnarizine on smooth muscles and cardiac tissues. Arch Int Pharmacodyn Ther 1973; 204:37-55.
29. Di Perri T, Forconi S, Guerrini M, et al. Action of cinnarizine on the hyperviscosity of blood in patients with peripheral obliterative arterial disease. Angiology 1979; 30:13-20.
30. De Cree J, De Cock W, Geukens H, et al. The rheological effects of cinnarizine and flunarizine in normal and pathologic conditions. Angiology 1979; 10:505-15.
31. Martinez DM. The effect of Serc (betahistine hydrochloride) on the circulation of the inner ear in experimental animals. Acta Otolaryngol 1972; 305(Suppl):29-47.
32. Laurikainen EA, Miller JM, Quirk WS, et al. Betahistine-induced vascular effects in the rat cochlea. Am J Otol 1993; 14:24-30.
33. Arrang JM, Garbarg M, Quack TT, et al. Action of betahistine and histamine receptors in the brain. Eur J Pharmacol 1986; 111:73-84.
34. Meyer ED. Treatment of Meniere's disease with betahistine dimesilate: Double-blind crossover study versus placebo. Laryngol Rhinol Otol Stuttg 1985; 64:269-72.
35. Weintraub J, Arenberg IK, Spector GJ, et al. The efficacy of conservative medical regimens on the rate of hearing loss in Meniere's syndrome: A retrospective computerized statistical analysis. Laryngoscope 1976; 86:1391-6.
36. Bertrand RA. Long-term evaluation of the treatment of Meniere's disease with betahistine HCl. Adv Otorhinolaryngol 1982; 28:104-10.
37. Thornton ARD, Farrell G, Haacke NP. A non-invasive, objective test of endolymphatic hydrops. Acta Otolaryngol (Stockh) 1991; 479(Suppl):35-43.
38. Futaki T, Semba T, Kudo Y. Treatment of hydropic patients by immunoglobulin with methyl B12. Am J Otol 1988; 9:131-5.
39. Itoh A, Sakata E. Treatment of vestibular disorders. Acta Otolaryngol (Stockh) 1991; 481(Suppl):617-23.
40. Brookes GB, Newland AC. Plasma exchange in the treatment of immune-mediated sensorineural hearing loss. J Laryngol Otol 1986; 100:25-33.
41. Schuknecht HF. Ablation therapy for the relief of Meniere's disease. Acta Otolaryngol (Stockh) 1957; 132(Suppl):14-42.
42. Graham MD, Sataloff RT, Kemink JL. Titration streptomycin therapy for bilateral Meniere's disease: A preliminary report. Otolaryngol Head Neck Surg 1984; 92:440-7.
43. Beck C, Schmidt CL. Ten years of experience with intratympanically applied streptomycin (gentamicin) in the therapy of morbus Meniere. Arch Otorhinolaryngol 1978; 221:149-52.
44. Wersall J, Bjorkroth F, Flock A, et al. Experiments on ototoxic effects of antibiotics. Adv Otorhinolaryngol 1973; 20:14-41
45. Nedzelski JM, Schessel DA, Bryce GE, et al. Chemical labyrinthectomy: Local application of gentamicin for the treatment of unilateral Meniere's disease. Am J Otol 1992; 13:18-22
46. Moller C, Odkvist LM, Thill J. Vestibular and audiologic functions in gentamicin treated Meniere's disease. Otolaryngol Head Neck Surg 1987; 9:383-91.
47. Odkvist LM. Middle ear ototoxic treatment for inner ear disease. Acta Otolaryngol (Stockh) 1989; 457(Suppl):83-6.
48. Pykko I, Ishizaki H, Kaasinen S, et al. Intratympanic gentamicin in bilateral Meniere's disease. Otolaryngol Head Neck Surg 1994; 110:162-7.